P3 Health Partners (PIII) Projected to Post Earnings on Thursday

P3 Health Partners (NASDAQ:PIII) is expected to be announcing its Q4 2025 results after the market closes on Thursday, March 26th. Analysts expect P3 Health Partners to post earnings of ($8.0633) per share and revenue of $357.65 million for the quarter. Individuals can find conference call details on the company’s upcoming Q4 2025 earning report page for the latest details on the call scheduled for Thursday, March 26, 2026 at 4:30 PM ET.

P3 Health Partners Stock Down 2.0%

Shares of P3 Health Partners stock opened at $2.97 on Wednesday. The company has a debt-to-equity ratio of 2.29, a quick ratio of 0.32 and a current ratio of 0.32. P3 Health Partners has a 52-week low of $1.52 and a 52-week high of $11.30. The stock has a market capitalization of $21.41 million, a price-to-earnings ratio of -0.07 and a beta of 0.86. The company’s 50 day moving average price is $2.48 and its 200-day moving average price is $5.27.

Analyst Upgrades and Downgrades

A number of equities research analysts recently commented on the stock. BTIG Research reiterated a “neutral” rating on shares of P3 Health Partners in a report on Friday, December 12th. Weiss Ratings reissued a “sell (e+)” rating on shares of P3 Health Partners in a report on Thursday, January 22nd. One research analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, P3 Health Partners currently has an average rating of “Hold” and a consensus price target of $12.50.

P3 Health Partners Company Profile

P3 Health Partners is a healthcare technology and services company that delivers data-driven solutions to support health plans in improving quality measures, risk adjustment accuracy and operational efficiency. The company’s platform integrates advanced analytics, reporting capabilities and workflow automation to help clients optimize performance across value-based care programs and regulatory requirements.

The company’s core offerings include quality measurement and reporting for HEDIS, STAR and other performance frameworks, risk adjustment coding and audit services, and population health analytics.